KALOBIOS PHARMACEUTICALS INC 4
4 · KALOBIOS PHARMACEUTICALS INC · Filed Jan 22, 2014
Insider Transaction Report
Form 4
Yarranton Geoffrey Thomas
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2014-01-19+75,000→ 75,000 totalExercise: $5.41Exp: 2024-01-19→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option shares will vest and become exercisable ratably over 48 months of continuous service after January 1, 2014.